The role of interleukin-17 in neurological disorders (2025)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB
- Unidades: IQ; ICB
- DOI: 10.1080/19768354.2025.2510994
- Subjects: FISIOLOGIA; INTERLEUCINAS; TRANSTORNOS MENTAIS; DOENÇAS NEURODEGENERATIVAS; CITOCINAS; DOENÇAS DO SISTEMA NERVOSO CENTRAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Animal Cells and Systems
- ISSN: 2151-2485
- Volume/Número/Paginação/Ano: v. 29, n. 1, p. 372-386, 2025
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PARKA, Seung Eun et al. The role of interleukin-17 in neurological disorders. Animal Cells and Systems, v. 29, n. 1, p. 372-386, 2025Tradução . . Disponível em: https://doi.org/10.1080/19768354.2025.2510994. Acesso em: 28 dez. 2025. -
APA
Parka, S. E., Ferreira, A. F. F., Kwon, H., Yu, J., Diniz, L., Kim, E., et al. (2025). The role of interleukin-17 in neurological disorders. Animal Cells and Systems, 29( 1), 372-386. doi:10.1080/19768354.2025.2510994 -
NLM
Parka SE, Ferreira AFF, Kwon H, Yu J, Diniz L, Kim E, Ulrich H, Britto LRG de. The role of interleukin-17 in neurological disorders [Internet]. Animal Cells and Systems. 2025 ; 29( 1): 372-386.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1080/19768354.2025.2510994 -
Vancouver
Parka SE, Ferreira AFF, Kwon H, Yu J, Diniz L, Kim E, Ulrich H, Britto LRG de. The role of interleukin-17 in neurological disorders [Internet]. Animal Cells and Systems. 2025 ; 29( 1): 372-386.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1080/19768354.2025.2510994 - Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model
- Mitochondrial abnormalities in neurological disorders
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
- Role of acetylcholine receptors in proliferation and differentiation of P19 embryonal carcinoma cells
- Participation of spontaneous 'CA POT. 2+'-transients and 'CA POT. 2+'-fluxes generated by purinergic and nicotinic acetylcholine receptors in neuronal differentiation of P19 embryonic carcinoma cells
Informações sobre o DOI: 10.1080/19768354.2025.2510994 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
